These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15200858)

  • 1. PorA variable regions of Neisseria meningitidis.
    Russell JE; Jolley KA; Feavers IM; Maiden MC; Suker J
    Emerg Infect Dis; 2004 Apr; 10(4):674-8. PubMed ID: 15200858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature.
    Sacchi CT; Lemos AP; Brandt ME; Whitney AM; Melles CE; Solari CA; Frasch CE; Mayer LW
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):845-55. PubMed ID: 9801347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine.
    Sorhouet Pereira C; Regueira M; Mollerach M
    J Med Microbiol; 2008 Mar; 57(Pt 3):338-342. PubMed ID: 18287297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.
    Jelfs J; Munro R; Wedege E; Caugant DA
    Clin Diagn Lab Immunol; 2000 May; 7(3):390-5. PubMed ID: 10799451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
    Clarke SC; Diggle MA; Mölling P; Unemo M; Olcén P
    Vaccine; 2003 Jun; 21(19-20):2468-73. PubMed ID: 12744880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
    Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
    J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.
    Tondella ML; Popovic T; Rosenstein NE; Lake DB; Carlone GM; Mayer LW; Perkins BA
    J Clin Microbiol; 2000 Sep; 38(9):3323-8. PubMed ID: 10970378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of PorA during a meningococcal disease epidemic.
    Devoy AF; Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):832-7. PubMed ID: 15695688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation.
    Arhin FF; Moreau F; Coulton JW; Mills EL
    Can J Microbiol; 1998 Jan; 44(1):56-63. PubMed ID: 9522450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.
    Suker J; Feavers IM; Maiden MCJ
    Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():63-69. PubMed ID: 8581171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
    van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
    Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.
    Sacchi CT; Whitney AM; Popovic T; Beall DS; Reeves MW; Plikaytis BD; Rosenstein NE; Perkins BA; Tondella ML; Mayer LW
    J Infect Dis; 2000 Oct; 182(4):1169-76. PubMed ID: 10979914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.
    McGuinness B; Barlow AK; Clarke IN; Farley JE; Anilionis A; Poolman JT; Heckels JE
    J Exp Med; 1990 Jun; 171(6):1871-82. PubMed ID: 1693651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.
    Martin SL; Borrow R; van der Ley P; Dawson M; Fox AJ; Cartwright KA
    Vaccine; 2000 May; 18(23):2476-81. PubMed ID: 10775781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system.
    Sacchi CT; Lemos AP; Whitney AM; Solari CA; Brandt ME; Melles CE; Frasch CE; Mayer LW
    Clin Diagn Lab Immunol; 1998 May; 5(3):348-54. PubMed ID: 9605990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation.
    Suker J; Feavers IM; Achtman M; Morelli G; Wang JF; Maiden MC
    Mol Microbiol; 1994 Apr; 12(2):253-65. PubMed ID: 8057850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
    Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
    Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design.
    Feavers IM; Fox AJ; Gray S; Jones DM; Maiden MC
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):444-50. PubMed ID: 8807211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain.
    Alcalá B; Salcedo C; Arreaza L; Abad R; Enríquez R; De La Fuente L; Uría MJ; Vázquez JA
    J Med Microbiol; 2004 Jun; 53(Pt 6):515-518. PubMed ID: 15150331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae.
    Feavers IM; Maiden MC
    Mol Microbiol; 1998 Nov; 30(3):647-56. PubMed ID: 9822829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.